A case for the booster dose |
Editorial
eMediNexus Coverage from: 
A case for the booster dose
Dr Veena Aggarwal, Consultant Womens’ Health, CMD and Editor-in-Chief, IJCP Group & Medtalks Trustee, Dr KK’s Heart Care Foundation of India,  03 December 2021
Coronavirus Live Count Map India

remove_red_eye 1973 Views
COVID-19 Vaccine Updates

Coronavirus Protocols

#Multispeciality

5 Read Comments                

The booster dose of the Pfizer-BioNTech mRNA vaccine reduced the chances of testing positive for SARS-CoV-2 by 86%, according to preliminary results from a short-term Israeli study reported in JAMA Internal Medicine on Tuesday.1The retrospective case-control study included 306,710 patients aged 40 years and older who were a part of an Israeli healthcare maintenance organization covering 2.5 million members. They were administered either 2 or 3 doses of the Pfizer-BioNTech (BNT162b2) mRNA va...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now